CohBar, Inc. (CWBR): Price and Financial Metrics

CohBar, Inc. (CWBR): $0.20

0.01 (+4.58%)

POWR Rating

Component Grades













Add CWBR to Watchlist
Sign Up

Industry: Biotech



in industry

CWBR Stock Price Chart Interactive Chart >

Price chart for CWBR

CWBR Price/Volume Stats

Current price $0.20 52-week high $2.27
Prev. close $0.19 52-week low $0.17
Day low $0.18 Volume 514,700
Day high $0.20 Avg. volume 542,208
50-day MA $0.25 Dividend yield N/A
200-day MA $0.55 Market Cap 17.09M

CohBar, Inc. (CWBR) Company Bio

CohBar, Inc., a biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. Its lead MBT drug candidates include CB4209 and CB4211, which are in IND-enabling studies for the treatment of fatty liver disease, non-alcoholic steatohepatitis, obesity, and type 2 diabetes mellitus. The company is also developing Humanin, a mitochondrial-derived peptide to treat Alzheimer's disease, atherosclerosis, myocardial and cerebral ischemia, and type 2 diabetes mellitus; SHLP-6 for the treatment of cancer; and SHLP-2 to treat Alzheimer's disease and type 2 diabetes mellitus. CohBar, Inc. was founded in 2007 and is headquartered in Menlo Park, California.

CWBR Latest News Stream

Event/Time News Detail
Loading, please wait...

CWBR Latest Social Stream

Loading social stream, please wait...

View Full CWBR Social Stream

Latest CWBR News From Around the Web

Below are the latest news stories about CohBar Inc that investors may wish to consider to help them evaluate CWBR as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, trader!

William White on InvestorPlace | February 3, 2022

Tri-Star Advisors Inc. Buys iShares TIPS Bond ETF, iShares Fallen Angels USD Bond ETF, BTC ...

Investment company Tri-Star Advisors Inc. (Current Portfolio) buys iShares TIPS Bond ETF, iShares Fallen Angels USD Bond ETF, BTC iShares MSCI USA Min Vol Factor ETF, BTC iShares Core MSCI EAFE ETF, iShares Agency Bond ETF, sells iShares 1-3 Year Credit Bond ETF, iShares Global Financials ETF, iShares Global Tech ETF, Vanguard S&P 500 ETF, Realty Income Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Tri-Star Advisors Inc..

Yahoo | January 13, 2022

CohBar to Present at H.C. Wainwright BIOCONNECT Conference

MENLO PARK, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that its Chief Executive Officer, Dr. Joseph Sarret, will present a company overview at the H.C. Wainwright BIOCONNECT Conference, being held virtually January 10 - 14, 2022. H.C. Wainwright

Yahoo | January 3, 2022

7 of the Best Penny Stocks Under $3 for 2022 to Buy Now

Penny stocks under $3 are full of potential and potential pitfalls.

Alex Sirois on InvestorPlace | December 31, 2021

CohBar, Inc. (NASDAQ:CWBR) Expected to Post Earnings of -$0.04 Per Share

Equities analysts expect CohBar, Inc. (NASDAQ:CWBR) to announce ($0.04) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have made estimates for CohBars earnings. CohBar reported earnings per share of ($0.08) in the same quarter last year, which suggests a positive year-over-year growth rate of 50%. The company is []

Dakota Financial News | December 19, 2021

Read More 'CWBR' Stories Here

CWBR Price Returns

1-mo -23.08%
3-mo -24.21%
6-mo -60.02%
1-year -84.00%
3-year -88.76%
5-year -88.57%
YTD -42.84%
2021 -73.89%
2020 -16.25%
2019 -48.55%
2018 -37.42%
2017 142.44%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1884 seconds.